Research identifies predictor of outcomes, chemoresistance for ovarian cancer patients
Newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Feb 27, 2024
0
37